[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global and China Neuromyelitis Optica Drug Market Research by Company, Type & Application 2013-2025

August 2019 | 80 pages | ID: G4BD3DB1EF5EN
HeyReport

US$ 2,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes pain in the eye and vision loss, and transverse myelitis, which causes weakness, numbness, and sometimes paralysis of the arms and legs, along with sensory disturbances and loss of bladder and bowel control. NMO leads to loss of myelin, which is a fatty substance that surrounds nerve fibers and helps nerve signals, move from cell to cell. The syndrome can also damage nerve fibers and leave areas of broken-down tissue. In the disease process of NMO, for reasons that aren't yet clear, immune system cells and antibodies attack and destroy myelin cells in the optic nerves and the spinal cord.Neuromyelitis optica drug is drug used in the treatment of neuromyelitis optica, in this report we focused on Glucocorticoids such as Methylprednisolone and Immunoglobulin such as IVIg.

Market Segment as follows:

By Type
  • Production Market Share
  • Price Rage
  • Cost
By Application
  • Acute attack
  • Remission prophylactic treatment
By Company
  • Pfizer
  • FRESENIUS
  • TEVA
  • SANDOZ
  • Intas
  • Gyjtrs
  • NANG KUANG
  • Tianjin Kingyork
  • Baxter
  • CSL
  • Grifols
  • Octapharma
  • CBOP
The main contents of the report including:

Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
1 MARKET OVERVIEW

1.1 Market Segment Overview
  1.1.1 Product Definition
  1.1.2 Market by Type
    1.1.2.1 Production Market Share
    1.1.2.2 Price Rage
    1.1.2.3 Cost
  1.1.3 Market by Application
    1.1.3.1 Acute attack
    1.1.3.2 Remission prophylactic treatment
1.2 Global and China Market Size
  1.2.1 Global Overview
  1.2.2 China Overview

2 GLOBAL AND CHINA MARKET BY COMPANY

2.1 Global
  2.1.1 Global Sales by Company
  2.1.2 Global Price by Company
2.2 China
  2.2.1 China Sales by Company
  2.2.2 China Price by Company

3 GLOBAL AND CHINA MARKET BY TYPE

3.1 Global
  3.1.1 Global Sales by Type
  3.1.2 Global Price by Type
3.2 China
  3.2.1 China Sales by Type
  3.2.2 China Price by Type

4 GLOBAL AND CHINA MARKET BY APPLICATION

4.1 Global
  4.1.1 Global Sales by Application
  4.1.2 Global Price by Application
4.2 China
  4.2.1 China Sales by Application
  4.2.2 China Price by Application

5 CHINA TRADE

5.1 Export
5.2 Import

6 KEY MANUFACTURERS

6.1 Pfizer
  6.1.1 Company Information
  6.1.2 Product Specifications
  6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 FRESENIUS
6.3 TEVA
6.4 SANDOZ
6.5 Intas
6.6 Gyjtrs
6.7 NANG KUANG
6.8 Tianjin Kingyork
6.9 Baxter
6.10 CSL
6.11 Grifols
6.12 Octapharma
6.13 CBOP

7 INDUSTRY UPSTREAM

7.1 Industry Chain
7.2 Raw Materials

8 MARKET ENVIRONMENT

8.1 SWOT
8.2 Porter's Five Forces

9 CONCLUSION

LIST OF TABLES

Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table China Market Sales Revenue by Company 2013-2017
Table China Market Sales Revenue Share by Company 2013-2017
Table China Market Sales Volume by Company 2013-2017
Table China Market Sales Volume Share by Company 2013-2017
Table China Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table China Market Sales Revenue by Type 2013-2017
Table China Market Sales Revenue Share by Type 2013-2017
Table China Market Sales Volume by Type 2013-2017
Table China Market Sales Volume Share by Type 2013-2017
Table China Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table China Market Sales Revenue by Application 2013-2017
Table China Market Sales Revenue Share by Application 2013-2017
Table China Market Sales Volume by Application 2013-2017
Table China Market Sales Volume Share by Application 2013-2017
Table China Price by Application 2013-2017
Table China Export 2013-2017 (Million USD)
Table China Export 2013-2017 (Volume)
Table China Import 2013-2017 (Million USD)
Table China Import 2013-2017 (Volume)
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Pfizer
Table Sales Revenue, Salels Volume, Price, Cost and Margin of FRESENIUS
Table Sales Revenue, Salels Volume, Price, Cost and Margin of TEVA
Table Sales Revenue, Salels Volume, Price, Cost and Margin of SANDOZ
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Intas
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Gyjtrs
Table Sales Revenue, Salels Volume, Price, Cost and Margin of NANG KUANG
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Tianjin Kingyork
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Baxter
Table Sales Revenue, Salels Volume, Price, Cost and Margin of CSL
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Grifols
Table Sales Revenue, Salels Volume, Price, Cost and Margin of Octapharma
Table Sales Revenue, Salels Volume, Price, Cost and Margin of CBOP

LIST OF FIGURES

Figure Production Market Share Market Size and CAGR 2013-2018 (Million USD)
Figure Production Market Share Market Size and CAGR 2013-2018 (Volume)
Figure Production Market Share Market Forecast and CAGR 2019-2025 (Million USD)
Figure Production Market Share Market Forecast and CAGR 2019-2025 (Volume)
Figure Price Rage Market Size and CAGR 2013-2018 (Million USD)
Figure Price Rage Market Size and CAGR 2013-2018 (Volume)
Figure Price Rage Market Forecast and CAGR 2019-2025 (Million USD)
Figure Price Rage Market Forecast and CAGR 2019-2025 (Volume)
Figure Cost Market Size and CAGR 2013-2018 (Million USD)
Figure Cost Market Size and CAGR 2013-2018 (Volume)
Figure Cost Market Forecast and CAGR 2019-2025 (Million USD)
Figure Cost Market Forecast and CAGR 2019-2025 (Volume)
Figure Acute attack Market Size and CAGR 2013-2018 (Million USD)
Figure Acute attack Market Size and CAGR 2013-2018 (Volume)
Figure Acute attack Market Forecast and CAGR 2019-2025 (Million USD)
Figure Acute attack Market Forecast and CAGR 2019-2025 (Volume)
Figure Remission prophylactic treatment Market Size and CAGR 2013-2018 (Million USD)
Figure Remission prophylactic treatment Market Size and CAGR 2013-2018 (Volume)
Figure Remission prophylactic treatment Market Forecast and CAGR 2019-2025 (Million USD)
Figure Remission prophylactic treatment Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Neuromyelitis Optica Drug Market Size and CAGR 2013-2017 (Million USD)
Figure Global Neuromyelitis Optica Drug Market Size and CAGR 2013-2017 (Volume)
Figure Global Neuromyelitis Optica Drug Market Forecast and CAGR 2019-2025 (Million USD)
Figure Global Neuromyelitis Optica Drug Market Forecast and CAGR 2019-2025 (Volume)
Figure China Neuromyelitis Optica Drug Market Size and CAGR 2013-2017 (Million USD)
Figure China Neuromyelitis Optica Drug Market Size and CAGR 2013-2017 (Volume)
Figure China Neuromyelitis Optica Drug Market Forecast and CAGR 2019-2025 (Million USD)
Figure China Neuromyelitis Optica Drug Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure China Market Sales Revenue Share by Company in 2017
Figure China Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure China Market Sales Revenue Share by Type in 2017
Figure China Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure China Market Sales Revenue Share by Application in 2017
Figure China Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Neuromyelitis Optica Drug SWOT List
Figure Neuromyelitis Optica Drug Porter's Five Forces


More Publications